Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Centessa Pharmaceuticals plc | 53,101 | reported | 21 Mar 2022 | tx 7+535,018 |
| Eleven Biotherapeutics, Inc. | 38,700 | reported | 01 Jul 2024 | tx 1+38,700 |
| Seres Therapeutics, Inc. | 22,500 | reported | 04 Mar 2026 | tx 3+1,372,500 |
| Evelo Biosciences, Inc. | 22,259 | reported | 08 Nov 2023 | tx 15+1,153,000−201,845 |
| Vallon Pharmaceuticals, Inc. |
| 9,506 |
| reported |
| 13 Dec 2022 |
| tx 4+60,523−28,517 |
| ESSA Pharma Inc. | 0 | reported | 09 Oct 2025 | tx 5+105,500−2,881 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | GRANT_AWARD | Seres Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 09 Oct 2025 | OTHER | ESSA Pharma Inc. | 2,881 | — | |
| 07 Feb 2025 | GRANT_AWARD | Seres Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 38,700 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | ESSA Pharma Inc. | 50,000 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | Seres Therapeutics, Inc. | 700,000 | 0.00 USD | deriv |
| 07 Nov 2023 | EXERCISE | Evelo Biosciences, Inc. | 6,500 | — | |
| 08 Nov 2023 | SALE | Evelo Biosciences, Inc. | 1,811 | 0.33 USD | |
| 07 Nov 2023 | EXERCISE | Evelo Biosciences, Inc. | 6,500 | 0.00 USD | deriv |
| 01 Nov 2023 | EXERCISE | Evelo Biosciences, Inc. | 12,500 | — | |
| 02 Nov 2023 | SALE | Evelo Biosciences, Inc. | 3,999 | 0.33 USD | |
| 01 Nov 2023 | EXERCISE | Evelo Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 11 Sept 2023 | GRANT_AWARD | Evelo Biosciences, Inc. | 37,500 | 0.00 USD | deriv |
| 07 Aug 2023 | EXERCISE | Evelo Biosciences, Inc. | 6,500 | — | |
| 08 Aug 2023 | SALE | Evelo Biosciences, Inc. | 2,004 | 9.51 USD | |
| 07 Aug 2023 | EXERCISE | Evelo Biosciences, Inc. | 6,500 | 0.00 USD | deriv |
| 08 May 2023 | SALE | Evelo Biosciences, Inc. | 38,531 | 0.13 USD | |
| 07 May 2023 | EXERCISE | Evelo Biosciences, Inc. | 130,000 | — | |
| 07 May 2023 | EXERCISE | Evelo Biosciences, Inc. | 130,000 | 0.00 USD | deriv |
| 07 Feb 2023 | GRANT_AWARD | Evelo Biosciences, Inc. | 520,000 | 0.00 USD | deriv |
| 13 Dec 2022 | OTHER | Vallon Pharmaceuticals, Inc. | 28,517 | 0.00 USD | |
| 29 Jun 2022 | GRANT_AWARD | ESSA Pharma Inc. | 22,500 | 0.00 USD | deriv |
| 01 Sept 2022 | GRANT_AWARD | Evelo Biosciences, Inc. | 440,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 38,023 | 0.00 USD | |
| 09 Jun 2022 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 7,500 | 0.00 USD | deriv |